Hawthorn (Crataegus sp.) is a traditional medicinal plant, which shows a broad spectrum of health-related effects. Drug preparation is based on material collected from wild growing plants, which usually show variability in their secondary metabolite composition and concentration. Plantations of selected hawthorn genotypes could form the basis of a consistent homogeneous source of top-quality hawthorn drugs. However, as hawthorn is a member of the Rosaceae family, such plantations would be threatened by the bacterial disease fire blight, which currently causes dramatic economic losses in apple and pear orchards. We show that prohexadione-Ca induces the formation in Crataegus monogyna leaves of the rare class of 3-deoxyflavonoids, which are responsible for better fire blight resistance and that the quality and quantity of the health related ingredients are not negatively influenced by prohexadione-Ca treatment.
Hawthorn (Crataegus sp., Rosaceae) is a traditional medicinal plant. Extracts from dried flowers, leaves and fruits are known to have beneficial effects on heart and blood vessels and, thus, are approved drugs for the treatment of mild cardiac and circulatory complaints [1] . The main pharmacologically active constitutents found in hawthorn [2] are flavone C-glycosides (vitexin, vitexin 2''-O-rhamnoside), flavonols [quercetin, hyperoside (quercetin-3-Ogalactoside)], (-)-epicatechin and oligomeric procyanidins (OPCs) (Figure 1 ). Whereas flavonols, epicatechin and OPCs are commonly formed in many plant species, the occurrence of flavone C-glycosides is quite limited [3] . Although flavonoid biosynthesis has been intensively studied in many plants, the formation of vitexin and ligomeric procyanidins is still unknown [4] .
A number of species exist within the genus Crataegus; in Middle Europe C. monogyna, C. laevigata and their hybrids are wide-spread [5] . Plant material from wild growing hawthorn, which usually shows a large variability, is the main source for drug production. Currently, local authorities promote the elimination of wild growing Rosaceae species (for example, hawthorn, crabapple, mountain ash, cotoneaster, rose, quince) in the close neighbourhood of orchards [6] to prevent the dissemination of fire blight. This Rosaceae specific disease is caused by the bacterium Erwinia amylovora, and causes dramatic losses in commercial apple and pear orchards. Plantations of selected Crataegus genotypes could provide a more homogeneous source and could also overcome the decreasing availability of wild growing hawthorn. However, this requires a protection strategy for fire blight in hawthorn. Apart from uprooting, the application of antibiotics, such as streptomycin, is a preferred method to control fire blight [7] . Concerning controversial discussions in European countries about possible risks for humans and the environment, the search for alternatives to antibiotics is an urgent matter.
NPC Natural Product Communications
One approach, which is used for the commercial protection of pome fruit trees, is the application of prohexadione-Ca. Originally developed as a plant growth regulator, prohexadione-Ca induces an enhanced resistance against fire blight, which is based on changes in flavonoid metabolism (Figure 2 ), in particular on the formation of antimicrobial 3-deoxyflavonoids [8] [9] [10] [11] [12] [13] [14] [15] . These changes are due to the competitive inhibition of the 2-oxoglutarate dependent dioxygenase flavanone 3-hydroxylase (FHT) by prohexadione-Ca. A prerequisite for the induced formation of 3-deoxyflavonoids after inhibition of the FHT is the ability of the plant to reduce accumulating flavanones at position 4. This may be catalyzed by dihydroflavonol 4-reductases (DFR) with flavanone 4-reductase (FNR) activity, as already shown for a number of important fruit crops [12] [13] [14] [15] .
We investigated whether prohexadione-Ca could be used for the protection of hawthorn against fire blight. Therefore, we tested whether the leaves have the potential to form 3-deoxyflavonoids and if prohexadione-Ca treatment has a comparable effect on the flavonoid metabolism of hawthorn, as previously described for apple trees. The main question was whether luteoliflavan, as an indicator of induced 3-deoxyflavonoids, is also found in hawthorn and how the induction proceeds. At the same time we investigated the pharmacologically active flavonoids for potential undesirable changes.
High activities could be observed for phenylalanine ammonium lyase (PAL), chalcone synthase/chalcone isomerase (CHS/CHI), flavanone 3-hydroxylase (FHT) and dihydrofavonol 4-reductase (DFR) in hawthorn leaves. In addition, FNR activity could be detected, although to a lower extent. In accordance with investigations on apple leaves, flavonol synthase (FLS) activity could not be demonstrated, despite the flavonol content of hawthorn leaves. To clarify whether DFR was responsible for the flavanone reduction, a cDNA clone was isolated (accession number: AY786995) based on the sequence information of DFR in the databases and characterized in detail. The recombinant enzyme showed both FNR and DFR activity: incubation of the heterologously expressed DFR with eriodictyol in the presence of NADPH led to the formation of luteoforol (Figure 3 ), whereas leucocyanidin was formed from DHQ.
Prohexadione-Ca treatment led to the inhibition of FHT for 9 days (Figure 4 ), a period which was significantly higher than that reported for rose leaves, but comparable to apple [14, 16] . As previously described for apple, not a complete blockage was
Transient observed, but a reduction of the activity to approximately 50% [16] . This creates a bottleneck in the flavonoid biosynthesis and results in an increased accumulation of flavonoids, which are formed earlier in the pathway and the formation of novel compounds, which are not found under standard conditions. For the other flavonoid enzymes, a general induction of the key enzymes of the flavonoid pathway could be observed after treatment with prohexadione-Ca (Figure 4 ). In case of CHS and DFR/FNR, an increased activity was observable for at least 9 days after treatment. PAL activity, however, showed a significant late induction in treated leaves compared to the control, as described for apple [16] .
The induction of gene expression and corresponding enzyme activities in prohexadione-Ca treated apple leaves was interpreted as an effect of feedback regulation by intermediary flavonoid metabolites [16] . Regarding the pharmacologically relevant compounds, the content of OPCs (up to 11%) dominated over flavone C-glycosides (up to 2.4%) and flavonols (up to 0.2%). Treatment with prohexadione-Ca did not negatively influence the spectrum of the pharmacologically active flavonoids. Fingerprint chromatograms of treated and untreated samples showed no significant differences. A typical finger print chromatogram of hawthorn is provided in Figure 5 .
The quantitative changes of selected flavonoids after treatment with prohexadione-Ca are shown in Figure 6 . The OPC contents remained unchanged over the whole investigation period and only slight changes could be observed for flavone C-glycosides ( Figure 6 ) and flavonols (data not shown). A possible speculation is that the general induction of the flavonoid metabolism accounted for the quite stable OPC contents despite the biochemical bottleneck generated by the treatment. A simultaneous accumulation of the 3-deoxycatechin luteoliflavan was observed with FHT inhibition in treated leaves. Furthermore, an increased formation of the constitutively formed eriodictyol-7-O-glucoside in treated plants was found ( Figure 6 ). Luteoliflavan concentrations were in the same scale as reported for apple (up to 0.1%) [8, 9, 16] . The immediate precursor in luteoliflavan formation, luteoforol, was identified as antimicrobially active compound, which is responsible for the enhanced disease resistance [17] . Thus, it is obvious that prohexadione-Ca has the same potential to protect hawthorn against fire blight as described for apple.
As the induced biosynthesis of antimicrobial 3-deoxyflavonoids is transient and only minor in comparison to the dominant biosynthesis of OPCs and flavone C-glycosides (Figure 6 ), the treatment of hawthorn trees with prohexadione-Ca should not interfere with the use of the plant material for drug preparation. Residual prohexadione-Ca in pharmaceutical Crataegus preparations from plantations could easily be avoided either by harvest of young leaves before prohexadione-Ca treatment, or by harvest after degradation of residual prohexadione-Ca after some weeks [18] , as usually practiced in commercial apple cultivation.
Experimental
Plant material: The studies were performed on Crataegus monogyna, growing in the garden of the Department of Pharmacognosy, University of Vienna in spring 2002. For enzymatic studies, a minimum of 100 young leaves and buds were frozen immediately after harvesting with liquid nitrogen, homogenized and stored at -80°C and used for the preparation of 
